Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Internist (Berl) ; 60(7): 690-700, 2019 Jul.
Article in German | MEDLINE | ID: mdl-31093686

ABSTRACT

Treatments in oncology, transplantation medicine and immunology frequently lead to immunodeficiency. This review presents the most important opportunistic neurologic infections, mostly of the central nervous system (CNS). Signs and symptoms, diagnostic procedures and therapeutic options are presented. The most frequent infections are due to varicella zoster virus (VZV), Cryptococcus neoformans and Toxoplasma gondii; JC virus (JCV) and cytomegalovirus (CMV) are rare causes of encephalitis. Differential diagnoses include infection by non-opportunistic causatives, therapy associated neurotoxicity, Epstein-Barr virus (EBV) associated CNS lymphoma, recurrence of the malignancy, as well as non-infectious diseases like intracranial bleeding, ischemic stroke, autoimmune diseases and posterior reversible leukencephalopathy syndrome. Treatment of these patients, moreover, needs to consider all previous therapies and to involve a neurologist.


Subject(s)
Central Nervous System/physiopathology , Cryptococcosis , Immunocompromised Host , Opportunistic Infections/complications , Toxoplasmosis , Varicella Zoster Virus Infection , Central Nervous System Diseases/etiology , Cryptococcosis/diagnosis , Cryptococcosis/etiology , Cryptococcus neoformans/isolation & purification , Encephalitis/etiology , Herpes Simplex/etiology , Herpesvirus 3, Human/isolation & purification , Humans , Leukoencephalopathy, Progressive Multifocal/etiology , Opportunistic Infections/diagnosis , Opportunistic Infections/virology , Toxoplasma , Toxoplasmosis/diagnosis , Toxoplasmosis/etiology , Varicella Zoster Virus Infection/diagnosis , Varicella Zoster Virus Infection/virology
2.
Acta Neurol Scand ; 137(3): 356-362, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29205262

ABSTRACT

BACKGROUND: In neurological diseases presenting with a plethora of symptoms, the value of bodily functions for a given patient might be a guide for clinical management. Multiple sclerosis (MS) is paradigmatic in this respect, and little is known about the value of different bodily functions of patients and their physicians' perceptions. METHODS: In a multicenter study, 171 patients with relapsing-remitting multiple sclerosis (RRMS), 61% with a clinically active disease within the last 2 years were followed over up to 3 years and yearly patients and their study physician rated on the perceived value of 13 bodily functions via a priority list. Differences between patients and physicians as well as modulating disease demographic factors were analyzed. RESULTS: Patients with RRMS rated visual function followed by thinking and memory and walking highest while physicians stressed mobility, followed by thinking and memory and alertness most. Ratings were independent from disease duration or disability. Strongest value judgment differences were seen in swallowing regarded more relevant by patients and hand function regarded more relevant by physicians. In general, patients' and physicians' ratings through time were quite stable. Collapsing physical items into a physical functioning scale and mental items in a mental function scale, both dimensions were regarded equally important by patients while physicians underscored physical functioning (P = .016). CONCLUSION: There are differences between patients and physicians in value statements of bodily functions in MS. In particular, visual functioning is under-recognized by physicians.


Subject(s)
Multiple Sclerosis, Relapsing-Remitting/complications , Multiple Sclerosis, Relapsing-Remitting/psychology , Adult , Female , Humans , Male , Middle Aged , Physicians , Surveys and Questionnaires
5.
Nervenarzt ; 75(8): 734-41, 2004 Aug.
Article in German | MEDLINE | ID: mdl-15034658

ABSTRACT

Infective endocarditis involves the brain in 20-40% of cases. The neurologic syndrome often is the presenting feature. The most frequent neurologic complication is cerebral ischemia. In these patients and those with intracranial hemorrhage, a heart murmur as well as systemic signs of inflammation point to endocarditis. The encephalopathy in endocarditis is mostly due to cerebral infarction. In bacterial meningitis and brain abscess an uncommon isolate arouses suspicion. The most important therapy is antibiotic treatment. Valve replacement improves outcome; in the acute phase of endocarditis, however, it is only necessary in a third of the patients. Neurologic complications interfere with the timing of the valve replacement. If it is urgently required, its risk is reasonable within 3 days after cerebral ischemia; if possible 2-4 weeks should be waited. Cases of successful valve replacement within 4 weeks after intracranial hemorrhage have been reported, but it is recommended to postpone it for 4-6 weeks. There are no data available for the other neurologic complications. Even today patients with endocarditis challenge the diagnostic and therapeutic capacity of various disciplines.


Subject(s)
Brain Diseases/diagnosis , Brain Diseases/therapy , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/therapy , Patient Care Management/methods , Brain Diseases/etiology , Brain Ischemia/diagnosis , Brain Ischemia/etiology , Brain Ischemia/therapy , Endocarditis, Bacterial/complications , Humans , Hypoxia-Ischemia, Brain/diagnosis , Hypoxia-Ischemia, Brain/etiology , Hypoxia-Ischemia, Brain/therapy
6.
Infection ; 32(1): 47-50, 2004 Feb.
Article in English | MEDLINE | ID: mdl-15007742

ABSTRACT

BACKGROUND: Bacterial meningitis is an unusual first manifestation but a major complication of infective endocarditis. PATIENTS AND METHODS: We present three well documented cases of isolated bacterial meningitis in endocarditis. Against this background we review the literature. RESULTS: All patients presented with bacterial meningitis. Staphylococcus aureus was isolated in blood cultures of all patients, but was found only in the cerebrospinal fluid (CSF) of one patient. The underlying endocarditis was confirmed histologically in all three cases. Two patients recovered completely and one died. CONCLUSION: An extensive search for endocarditis is recommended in every case of an unusual isolate in bacterial meningitis whether it is isolated from blood or CSF.


Subject(s)
Endocarditis, Bacterial/diagnosis , Meningitis, Bacterial/diagnosis , Pseudomonas Infections/diagnosis , Sepsis/diagnosis , Staphylococcal Infections/diagnosis , Aged , Anti-Bacterial Agents , Diagnosis, Differential , Drug Therapy, Combination/therapeutic use , Echocardiography, Transesophageal/methods , Endocarditis, Bacterial/complications , Endocarditis, Bacterial/drug therapy , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging/methods , Meningitis, Bacterial/complications , Meningitis, Bacterial/drug therapy , Middle Aged , Pseudomonas Infections/complications , Pseudomonas Infections/drug therapy , Risk Assessment , Sepsis/complications , Sepsis/drug therapy , Severity of Illness Index , Staphylococcal Infections/complications , Staphylococcal Infections/drug therapy , Treatment Outcome
8.
Eur J Immunol ; 31(7): 2104-15, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11449364

ABSTRACT

Central nervous system (CNS) infections caused by Streptococcus pneumoniae still have a disastrous outcome. Underlying immunological and CNS cellular events are largely enigmatic. We used pneumococcal cells walls (PCW) to investigate microglial responses as these cells are prominent sensors and effectors during neuropathological changes. PCW stimulation of mouse microglia in vitro evoked the release of the cyto- and chemokines, TNF-alpha, IL-6, IL-12, KC, MCP-1, MIP-1alpha, MIP-2 and RANTES as well as soluble TNF receptor II, a potential TNF-alpha antagonist. The release induction followed extremely steep dose-response relations, and short exposure periods (15 min) were already sufficient to trigger substantial responses. PCW signaling controlling the release depended on both p38 and p42/p44 (ERK2/ERK1) MAP kinase activities. The kinase inhibitor, tyrphostin AG126 prevented the PCW-inducible phosphorylation of p42/p44(MAPK), potently blocked cytokine release and drastically reduced the bioavailable TNF-alpha, since it only marginally affected the release of soluble TNF receptors. Moreover, in an in vivo model of pneumococcal meningitis, AG126 significantly attenuated the PCW-induced leukocyte influx to the cerebrospinal fluid. The findings imply that pneumococcal CNS infection can cause a rapid and massive microglial activation and that ERK/MAPK pathway(s) are potential targets for pharmacological interventions.


Subject(s)
Cytokines/biosynthesis , Enzyme Inhibitors/pharmacology , Meningitis, Pneumococcal/immunology , Microglia/immunology , Protein-Tyrosine Kinases/antagonists & inhibitors , Tyrphostins/pharmacology , Animals , Cell Wall/immunology , Cells, Cultured , Chemokines/biosynthesis , MAP Kinase Kinase 1 , MAP Kinase Kinase 2 , Male , Mice , Microglia/drug effects , Mitogen-Activated Protein Kinase 1/physiology , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinases/physiology , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , Rats , Rats, Wistar , Receptors, Tumor Necrosis Factor/biosynthesis , Streptococcus pneumoniae/immunology , Tumor Necrosis Factor-alpha/biosynthesis , p38 Mitogen-Activated Protein Kinases
9.
J Cereb Blood Flow Metab ; 20(5): 834-8, 2000 May.
Article in English | MEDLINE | ID: mdl-10826534

ABSTRACT

Pneumococcal meningitis resulting from Streptococcus pneumoniae has a death rate of 28% in adults. In severe head injury and stroke, inflammatory changes and intracranial hypertension are improved by induced hypothermia, which also is neuroprotective. We hypothesized that moderate hypothermia ameliorates inflammatory changes in experimental pneumococcal meningitis. Wistar rats were cooled systemically, and meningitis was induced by pneumococcal cell wall components. The increase of regional cerebral blood flow in the meningitis animals was blocked by hypothermia at 6 hours. The reduction of intracranial pressure correlated with temperature. The influx of leukocytes into the cerebrospinal fluid and levels of tumor necrosis factor alpha in the cerebrospinal fluid were decreased. Cooling the animals 2 hours after meningitis induction to 30.5 degrees C was also protective. We conclude that hypothermia is a new adjuvant approach to reduce meningitis-induced changes, in particular intracranial pressure, in the early phase of the disease.


Subject(s)
Hypothermia, Induced , Meningitis, Pneumococcal/therapy , Animals , Cerebrospinal Fluid/cytology , Cerebrovascular Circulation , Intracranial Pressure , Male , Meningitis, Pneumococcal/cerebrospinal fluid , Meningitis, Pneumococcal/physiopathology , Rats , Rats, Wistar , Time Factors , Tumor Necrosis Factor-alpha/cerebrospinal fluid
10.
J Immunol ; 163(8): 4308-14, 1999 Oct 15.
Article in English | MEDLINE | ID: mdl-10510370

ABSTRACT

TNF-alpha, inducible NO synthase (iNOS), and ICAM-1 are considered to be key proteins in the inflammatory response of most tissues. We tested the hypothesis that cell walls of Streptococcus pneumoniae (PCW), the most common cause of adult bacterial meningitis, induce TNF-alpha, iNOS, and ICAM-1 expression in rat primary brain microvascular endothelial cell cultures. We detected TNF-alpha mRNA by RT-PCR already 1 h after stimulation with PCW, while TNF-alpha protein peaked at 4 h (9.4 +/- 3.6 vs 0.1 +/- 0.1 pg/microgram protein). PCW induced iNOS mRNA 2 h after stimulation, followed by an increase of the NO degradation product nitrite (18.1 +/- 4 vs 5.8 +/- 1.8 at 12 h; 18.1 +/- 4 vs 5.8 +/- 1.8 pmol/microgram protein at 72 h). The addition of TNF-alpha Ab significantly reduced nitrite production to 62.2 +/- 14.4% compared with PCW-stimulated brain microvascular endothelial cells (100%). PCW induced the expression of ICAM-1 (measured by FACS), which was completely blocked by TNF-alpha Ab (142 +/- 18.6 vs 97.5 +/- 12.4%; 100% unstimulated brain microvascular endothelial cells). Cerebral endothelial cells express TNF-alpha mRNA as well as iNOS mRNA and release the bioactive proteins in response to PCW. PCW-induced NO production is mediated in part by an autocrine pathway involving TNF-alpha, whereas ICAM-1 expression is completely mediated by this autocrine loop. By these mechanisms, cerebral endothelial cells may regulate critical steps in inflammatory blood-brain-barrier disruption of bacterial meningitis.


Subject(s)
Brain/immunology , Cell Wall/immunology , Endothelium, Vascular/immunology , Intercellular Adhesion Molecule-1/biosynthesis , Nitric Oxide Synthase/biosynthesis , Streptococcus pneumoniae/immunology , Tumor Necrosis Factor-alpha/metabolism , Animals , Autocrine Communication/immunology , Brain/cytology , Brain/drug effects , Brain/metabolism , Cells, Cultured , Dexamethasone/pharmacology , Dose-Response Relationship, Immunologic , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Guanidines/pharmacology , Immune Sera/pharmacology , Kinetics , Microcirculation/immunology , Microcirculation/metabolism , Nitric Oxide/metabolism , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type II , Nitroarginine/pharmacology , RNA, Messenger/biosynthesis , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology , Up-Regulation/immunology
11.
Neuroscience ; 86(2): 627-34, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9881875

ABSTRACT

Although tumour necrosis factor alpha is said to play a key role in bacterial meningitis and other CNS diseases, the effects of this pro-inflammatory cytokine have only been studied in part and are incompletely understood. In a rat model, we investigated the effect of intracisternal injection of recombinant rat-specific tumour necrosis factor alpha (5, 35, 70 and 280 microg tumour necrosis factor alpha) (i) alone, (ii) combined with pneumococcal cell wall components, on regional cerebral blood flow, intracranial pressure, white blood cell count in the cerebrospinal fluid, and brain water content. Tumour necrosis factor a dose-dependently caused an increase in regional cerebral blood flow (up to 221 +/- 43% of baseline values) over the six hour observation period and mild cerebrospinal fluid leukocytosis; intracranial pressure and brain water content were unchanged. Hypothesizing that regional cerebral blood flow changes are dependent on nitric oxide, tumour necrosis factor alpha-induced regional cerebral blood flow increase was abolished by Aminoguanidine, a selective inhibitor of inducible nitric oxide synthase. Combination of the lowest tumour necrosis factor alpha dose and a low dose pneumococcal cell wall preparation magnified the inflammatory effect of both. We conclude that intrathecally injected tumour necrosis factor alpha alone results in only minor inflammatory changes, whereas it dramatically augments experimental meningitis.


Subject(s)
Brain/physiopathology , Inflammation/physiopathology , Meningitis, Pneumococcal/physiopathology , Tumor Necrosis Factor-alpha/pharmacology , Animals , Body Water/metabolism , Brain/blood supply , Brain/drug effects , Cell Wall , Cerebrovascular Circulation/drug effects , Dose-Response Relationship, Drug , Guanidines/pharmacology , Intracranial Pressure/drug effects , Intracranial Pressure/physiology , Leukocyte Count , Male , Rats , Rats, Wistar , Recombinant Proteins/administration & dosage , Recombinant Proteins/pharmacology , Regional Blood Flow/drug effects , Streptococcus pneumoniae , Tumor Necrosis Factor-alpha/administration & dosage , Tumor Necrosis Factor-alpha/physiology
12.
J Cereb Blood Flow Metab ; 17(11): 1221-9, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9390654

ABSTRACT

Heparin is a natural proteoglycan that was first described in 1916. In addition to its well characterized effect on blood coagulation, it is becoming clear that heparin also modulates inflammatory processes on several levels, including the interference with leukocyte-endothelium interaction. Anecdotal observations suggest a better clinical outcome of heparin-treated patients with bacterial meningitis. The authors demonstrate that heparin, a glycosaminoglycan, inhibits significantly in the early phase of experimental pneumococcal meningitis the increase of 1) regional cerebral blood flow (125 +/- 18 versus 247 +/- 42%), 2) intracranial pressure (4.5 +/- 2.0 versus 12.1 +/- 2.2 mm Hg), 3) brain edema (brain water content: 78.23 +/- 0.33 versus 79.49 +/- 0.46%), and 4) influx of leukocytes (571 +/- 397 versus 2400 +/- 875 cells/microL) to the cerebrospinal fluid compared with untreated rats. To elucidate the possible mechanism of this observation, the authors investigated for the first time leukocyte rolling in an inflammatory model in brain venules by confocal laser scanning microscopy in vivo. Heparin significantly attenuates leukocyte rolling at 2, 3, and 4 hours (2.8 +/- 1.3 versus 7.9 +/- 3.2/100 microm/min), as well as leukocyte sticking at 4 hours (2.1 +/- 0.4 versus 3.5 +/- 1.0/100 microm/min) after meningitis induction compared with untreated animals. The authors conclude that heparin can modulate acute central nervous system inflammation and, in particular, leukocyte-endothelium interaction, a key process in the cascade of injury in bacterial meningitis. They propose to evaluate further the potential of heparin in central nervous system inflammation in basic and clinical studies.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Heparin/pharmacology , Leukocytes/drug effects , Meningitis, Bacterial/blood , Animals , Brain Edema/metabolism , Cell Adhesion/drug effects , Cerebrovascular Circulation/drug effects , Heparitin Sulfate/pharmacology , Intracranial Pressure/drug effects , Leukocytes/physiology , Male , Rats , Rats, Wistar
13.
Neurosci Lett ; 226(1): 17-20, 1997 Apr 18.
Article in English | MEDLINE | ID: mdl-9153631

ABSTRACT

The present study tested the hypothesis whether a histamine dependent pathway is involved in leukocyte-endothel interaction in the early phase of bacterial meningitis. Using confocal laser scanning microscopy we investigated leukocyte rolling in brain venules in vivo during 4 h in experimental pneumococcal meningitis in the rat. Leukocyte rolling, but not firm adhesion induced by intracisternally (i.c.) injected pneumococcal cell wall components, was temporarily inhibited (2 h, 5.6 +/- 1.9 vs. 2.3 +/- 0.9; 3 h, 7.4 +/- 2.7 vs. 3.1 +/- 1.3/100 microm/min) by diphenhydramine, a histamine H1 receptor antagonist. Histamine, possibly released by activated mast cells, is known to initiate P-selectin upregulation and subsequent leukocyte rolling. This data suggest that histamine is a mediator of leukocyte rolling in the early phase of bacterial meningitis.


Subject(s)
Diphenhydramine/pharmacology , Histamine/pharmacology , Leukocytes/drug effects , Meningitis, Bacterial/drug therapy , Animals , Disease Models, Animal , Male , Rats , Rats, Wistar , Time Factors
14.
J Cereb Blood Flow Metab ; 16(6): 1143-52, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8898686

ABSTRACT

We investigated the role of nitric oxide (NO) in leukocyte-endothelium interaction, blood-brain barrier (BBB) function and oxygen free-radical production in the rat pial microcirculation. In a closed cranial window preparation (dura removed) over the parietal cortex of pentobarbital-anesthetized Wistar rats, NO synthase (NOS) was inhibited by systemic and/or topical application of N omega-nitro-L-arginine (L-NNA) under physiological conditions and during leukotriene B4 (LTB4) activation. Circulating leukocytes were labeled by intravenous injection of rhodamine 6G. We used a confocal laser scanning microscope (CLSM) and studied leukocyte rolling and sticking in pial veins and arteries before and after NOS inhibition. At the end of the experiments, sodium-fluorescein was injected intravenously to test BBB integrity. Brain cortex oxygen free-radical production was investigated in the cranial window preparation using lucigenin-enhanced chemiluminescence (CL). L-NNA application did not lead to significant changes in leukocyte-endothelium interaction, BBB function, and oxygen free-radical production under physiological conditions [leukocyte-endothelium interaction: control (n = 5), L-NNA systemically (n = 5), L-NNA topically (n = 5): at baseline rollers/100 microns: 0.76 +/- 0.55, 0.64 +/- 0.94, 0.44 +/- 0.55 and stickers/100 microns: 0.90 +/- 0.28, 0.76 +/- 0.24, 0.84 +/- 0.42; at 60 min rollers/100 microns: 1.49 +/- 0.66, 1.21 +/- 0.99, 0.67 +/- 0.66 and stickers/100 microns: 1.04 +/- 0.20, 1.19 +/- 0.23, 1.21 +/- 0.54; oxygen free-radical production (n = 4): CL count before L-NNA application 35 +/- 17 cps, after 1 h of topical superfusion of L-NNA 38 +/- 14 cps; p < 0.05]. In contrast to the results achieved under physiological conditions, a significant further increase of rolling leukocytes and BBB permeability occurred due to NOS inhibition under LTB4-activated conditions [76 +/- 47% significant (p < or = 0.01, n = 7) further increase of rollers/100 microns due to 60 min L-NNA application following the activation period of 120 min LTB4 superfusion]. Our results support a modulatory role for NO in leukocyte-endothelium interaction and BBB permeability in the pial microcirculation when this interaction is increased.


Subject(s)
Blood-Brain Barrier , Cerebral Veins/pathology , Endothelium, Vascular/pathology , Leukocytes/pathology , Nitric Oxide Synthase/metabolism , Animals , Cell Adhesion/drug effects , Cerebral Veins/metabolism , Endothelium, Vascular/metabolism , Enzyme Inhibitors/pharmacology , Leukocytes/metabolism , Male , Microscopy, Confocal , Nitric Oxide Synthase/antagonists & inhibitors , Nitroarginine/pharmacology , Rats , Rats, Wistar
15.
J Cereb Blood Flow Metab ; 16(6): 1319-24, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8898707

ABSTRACT

We investigated whether trigeminal nerve fibers contribute to enhanced regional cerebral blood flow (rCBF) in a rat model of experimental bacterial meningitis. rCBF was measured continuously for 6 h by laser Doppler flowmetry through thinned bone over the frontal cortex. Meningitis was induced with pneumococcal cell wall components and confirmed by a significant increase of (a) leukocytes within the cerebrospinal fluid, (b) brain water content, (c) intracranial pressure and (d) rCBF. The increase of rCBF was significantly attenuated (p < 0.05) at 3, 4, 5, and 6 h in animals after a chronic (200 +/- 21% versus 138 +/- 13% at 6 h on the intact and denervated sides, respectively) but not after an acute section of the nasociliary branch of the trigeminal nerve. We conclude that elevations in blood flow during the early phase of bacterial meningitis are mediated in part by the trigeminal nerve, probably by local perivascular release of neuropeptides from afferent axons innervating the meninges.


Subject(s)
Cerebrovascular Circulation , Meningitis, Bacterial/physiopathology , Trigeminal Nerve/physiopathology , Animals , Laser-Doppler Flowmetry , Male , Rats , Rats, Wistar
16.
J Neuroimmunol ; 63(1): 63-8, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8557826

ABSTRACT

We investigated whether monoclonal antibodies directed against intracellular adhesion molecule 1 (ICAM-1 mAb) inhibit brain edema, increase of intracranial pressure (ICP), regional cerebral blood flow (rCBF) and recruitment of white blood cells (WBC) into the cerebrospinal fluid (CSF) in the rat model of the early phase of bacterial meningitis. Brain edema was assessed by brain water content determinations. rCBF measured by laser Doppler flowmetry and ICP were recorded continuously for 6 h after intracisternal challenge. Meningitis was induced with pneumococcal cell walls (PCW). Increase of ICP and brain water content were significantly inhibited (P <0.05) by intravenous treatment with ICAM-1 mAb (TM-8, 1 mg/kg). Furthermore, ICAM-1 mAb treatment profoundly attenuated (P <0.05) rCBF increase and WBC invasion into the CSF. These results suggest that the ICAM-1 pathway is critically involved in the early phase of bacterial meningitis.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Intercellular Adhesion Molecule-1/physiology , Meningitis, Bacterial/therapy , Animals , Cerebrovascular Circulation , Intracranial Pressure , Male , Meningitis, Bacterial/physiopathology , Rats , Rats, Wistar
17.
Neurosci Lett ; 191(1-2): 1-4, 1995 May 19.
Article in English | MEDLINE | ID: mdl-7659273

ABSTRACT

It is presumed that adjuvant therapy rather than new antibiotics will improve the prognosis of pneumococcal meningitis. We investigated the effect of fucoidin, a polysaccharide inhibiting leukocyte rolling, on inflammatory changes in experimental meningitis in rats. After induction of meningitis by pneumococcal cell wall components, regional cerebral blood flow and intracranial pressure increased over the observation period of 6 h. At the end of the experiments, cerebrospinal fluid pleocytosis and brain water content were higher in animals with meningitis than without. Fucoidin treatment in the meningitis group reduced all inflammatory changes, whereas fucoidin treatment of animals without meningitis increased blood white cell count, but had no effect on any other parameter. Our results confirm that selectins are involved in the early phase of pneumococcal meningitis and possibly are a target for adjunctive therapy.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Anticoagulants/pharmacology , Leukocytes/drug effects , Meningitis, Pneumococcal/pathology , Polysaccharides/pharmacology , Animals , Blood Gas Analysis , Blood Pressure/drug effects , Brain Edema/drug therapy , Brain Edema/pathology , Cerebrovascular Circulation/drug effects , Intracranial Pressure/drug effects , Leukocyte Count/drug effects , Male , Meningitis, Pneumococcal/physiopathology , Rats , Rats, Wistar
18.
Invest Ophthalmol Vis Sci ; 35(6): 2741-8, 1994 May.
Article in English | MEDLINE | ID: mdl-8188467

ABSTRACT

PURPOSE: To verify whether or not an accelerated loss at an older age for normal sensitivity in the central visual field is present when using the stimulus configuration of conventional white/white automated light-sense perimetry and the stimulus configuration of the automated flicker perimeter developed by one of the authors (BJL). METHODS: One hundred thirty eyes of 130 normal subjects aged 9 to 86 years were tested with the Humphrey-Field-Analyzer 640, program 30-2, and our automated flicker perimeter. In addition, short introductory learning programs were used for both techniques. All tests were performed in random order. RESULTS: Mean critical flicker fusion frequency shows a linear loss over the entire age range (r = -0.5546, P < 0.0001, slope a = -0.3820 dB/decade), whereas mean light difference sensitivity decreases only slightly up to 46 years of age (r = -0.0118, P = 0.9226, slope a = -0.0153 dB/decade), with a marked acceleration above 46 years of age (r = -0.7304, P < 0.0001, slope a = -2.0640 dB/decade). CONCLUSIONS: The absence of an accelerated loss at an older age for critical flicker fusion frequency (CFF) and the presence of such a loss for light-difference sensitivity (LDS) might be attributed to the independence of a flickering stimulus from distributing effects induced by the ocular media at an older age as proposed by one of the authors. The different age effects for CFF and LDS could also be explained by different age-related losses at different sites and for different neuronal populations throughout the visual pathways.


Subject(s)
Aging/physiology , Flicker Fusion/physiology , Visual Perception , Adolescent , Adult , Aged , Aged, 80 and over , Child , Female , Humans , Male , Middle Aged , Sensitivity and Specificity , Sensory Thresholds , Visual Field Tests/methods , Visual Fields/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...